| Ponatinib |
ENSG00000031544.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000088970.11 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000104691.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000118412.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000124835.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000124915.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000125804.9 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000132204.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000135253.9 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000136315.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000146666.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000149656.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000152487.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000152487.6 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000152487.6 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000153363.8 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000153363.8 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000157306.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000157306.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000163364.5 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000163597.10 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000167912.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000170161.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000170590.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000171889.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000172250.10 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000172965.10 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000172965.10 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000173867.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000174171.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000174171.4 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000174365.15 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000175061.13 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000175147.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000175147.7 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000175611.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000175701.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000175773.8 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000175773.8 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000175773.8 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000176728.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000177337.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000177640.11 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000177822.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000177853.10 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000178440.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000178803.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000178803.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000178947.8 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000179141.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000179743.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000179935.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000180139.10 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000180422.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000180458.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000180846.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000182057.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000182109.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000182165.13 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000182165.13 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000182376.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000182376.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000182648.7 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000182648.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000183535.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000183674.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000184274.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000184274.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000184274.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000184274.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000184274.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000185044.10 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000185168.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000185168.5 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000185186.4 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000185203.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000185495.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000185837.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000185847.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000185904.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000185904.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000185904.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000186019.10 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000186594.8 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000186842.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000186842.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000187229.3 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000188206.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000188365.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000188660.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000189196.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000189223.9 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000196243.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000196421.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000196553.9 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000196668.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000196668.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000196668.3 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000196810.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000196810.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000196951.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000197210.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000197210.7 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000197291.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000197332.7 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000197558.7 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000197813.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000197989.9 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000198468.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000203280.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000203280.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000203321.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000203321.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000203325.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000203327.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000203335.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000203356.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000203356.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000203356.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000203362.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000203441.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000203441.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000203496.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000203496.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000203496.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000203499.6 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000203650.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000203650.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000203801.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000203808.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000203808.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000203849.6 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000203849.6 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000203886.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000203987.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000203999.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000203999.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000204011.4 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000204044.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000204091.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000204110.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000204119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000204362.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000204588.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000204588.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000204625.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000204706.10 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000204706.10 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000204706.10 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000204791.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000204792.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000204792.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000204792.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000204802.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000204815.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000204837.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000204934.6 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000205041.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000205041.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000205056.8 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000205293.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000205424.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000205444.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000205500.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000205500.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000205500.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000205628.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000205632.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000205662.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000205662.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000205890.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000205913.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000206142.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000206176.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000206176.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000206195.6 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000206417.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000206573.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000211683.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000212163.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000212694.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000212694.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000213468.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000213468.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000213742.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000213963.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000213963.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000214105.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000214546.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000214559.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000214650.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000214719.7 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000214725.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000214770.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000214770.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000214770.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000214773.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000214783.5 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000214837.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000214955.5 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000215039.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000215159.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000215159.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000215190.4 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000215241.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000215241.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000215256.3 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000215417.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000215424.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000215447.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000215483.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000215692.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000215692.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000215808.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000215841.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000215863.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000215866.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000215908.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000216863.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000217576.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000219159.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000219665.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000219665.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000219665.4 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000220161.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000220161.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000220925.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000222032.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000222041.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000222041.6 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000223356.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000223356.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000223356.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000223356.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000223374.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000223379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000223380.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000223380.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000223382.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000223396.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000223401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000223461.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000223466.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000223473.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000223485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000223486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000223511.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000223528.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000223537.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000223552.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000223561.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000223573.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000223576.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000223598.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000223652.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000223653.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000223660.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000223669.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000223669.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000223685.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000223697.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000223725.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000223745.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000223754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000223759.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000223759.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000223764.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000223768.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000223770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000223791.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000223791.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000223799.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000223829.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000223834.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000223834.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000223842.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000223855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000223882.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000223884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000223884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000223891.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000223935.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000223949.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000223956.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000223960.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000223960.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000223969.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000223975.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000223975.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000224000.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224020.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000224020.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000224023.6 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000224031.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000224031.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224032.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224034.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000224043.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224043.3 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000224046.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000224050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224078.8 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224093.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000224101.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000224128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224142.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224174.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000224189.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224238.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000224269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224271.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000224271.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000224276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224281.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000224292.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000224356.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224356.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000224358.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224358.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224358.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000224387.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000224387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224429.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224441.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000224490.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224490.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000224525.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224536.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000224541.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000224541.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224568.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224574.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224596.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224597.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000224609.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224614.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000224614.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000224616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224621.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000224649.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000224671.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224687.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000224699.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224713.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224713.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224743.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224789.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000224794.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224812.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224818.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000224843.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000224849.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224883.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224885.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224885.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000224888.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000224888.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000224905.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000224930.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000224959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224959.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000224969.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000224977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000224977.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000224977.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000224977.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000224995.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225037.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000225039.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225039.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000225057.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225057.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000225064.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225075.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000225075.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000225075.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000225077.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000225092.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000225111.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225138.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225156.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225187.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225187.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000225194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225210.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000225218.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225226.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225234.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225234.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000225255.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225269.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225278.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225278.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000225278.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000225280.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225285.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000225300.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225302.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000225335.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000225335.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000225353.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000225353.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225361.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000225393.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000225393.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000225411.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225411.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000225411.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225413.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225417.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225431.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225439.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000225439.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000225439.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000225439.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225465.6 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225493.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000225493.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000225498.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000225506.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000225518.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000225527.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225532.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225546.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225572.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225578.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000225595.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000225595.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225606.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225643.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225675.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000225675.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000225675.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000225676.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225684.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225721.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000225721.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000225725.4 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000225725.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000225725.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000225731.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000225744.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000225761.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000225762.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000225793.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000225836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225857.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000225891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225905.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225930.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225930.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225946.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225948.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000225952.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225963.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000225969.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000225978.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000225981.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000226007.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000226009.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226009.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000226026.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000226029.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226051.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226053.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000226067.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226067.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000226067.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226087.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226113.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226149.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226172.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226245.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000226251.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000226276.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226308.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000226310.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000226310.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000226312.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226330.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226352.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226367.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000226374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226380.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000226381.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000226383.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226386.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000226390.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226465.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226472.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000226476.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226562.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000226581.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226598.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226609.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226609.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000226627.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226629.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000226649.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000226649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226649.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000226661.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000226699.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000226702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226709.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226746.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226747.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000226752.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000226754.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000226758.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000226786.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226786.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000226786.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000226786.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000226791.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226822.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000226851.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226852.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000226856.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000226862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226869.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000226876.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000226876.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000226877.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226877.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226891.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226904.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226904.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226904.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000226913.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000226920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000226920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226957.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000226957.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226965.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000226985.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000227006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000227028.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227036.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000227036.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227036.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000227039.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227060.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227070.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000227071.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000227091.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227110.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000227112.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227116.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227117.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000227155.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000227165.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227172.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000227188.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000227197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227197.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000227200.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000227210.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000227210.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227214.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000227215.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000227218.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227245.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000227253.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227256.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227279.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000227285.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000227285.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227352.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227354.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000227354.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000227354.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000227372.6 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000227372.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000227374.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000227374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227388.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000227392.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227398.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000227407.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000227486.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227487.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000227487.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227495.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000227496.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000227496.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000227496.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000227502.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000227542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000227542.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000227542.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000227555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227589.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000227589.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000227589.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227589.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000227598.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000227617.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000227617.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227619.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000227627.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000227627.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000227630.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000227637.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000227674.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000227678.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227681.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000227698.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000227698.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000227698.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000227702.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227704.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227733.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000227740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000227741.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000227811.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227877.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000227888.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000227895.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227896.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000227911.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227920.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000227925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227945.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000227945.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000227953.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000228005.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000228013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228016.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000228016.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228021.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000228022.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000228060.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228060.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000228060.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000228065.6 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000228079.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228108.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228113.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000228115.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228133.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228135.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000228135.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228137.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000228139.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228153.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228172.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000228192.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228192.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000228192.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000228204.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228242.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000228251.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228293.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000228293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228294.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000228302.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228315.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228327.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228340.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000228350.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000228350.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000228350.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000228352.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228352.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000228363.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228363.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000228363.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000228386.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000228386.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000228389.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000228389.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228412.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228430.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228436.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000228437.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000228486.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228487.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000228506.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000228509.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000228512.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228526.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000228527.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000228549.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000228554.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000228561.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000228573.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228604.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000228614.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000228614.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000228624.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000228624.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000228625.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228629.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228643.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000228649.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000228661.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000228661.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000228677.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000228677.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000228679.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000228679.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228679.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000228679.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228697.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000228701.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000228719.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000228723.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228737.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000228742.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000228742.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228742.5 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000228763.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000228775.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228775.3 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000228784.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228786.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000228791.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000228792.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228794.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228794.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228809.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000228839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228839.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000228862.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228889.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228933.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000228939.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000228973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000228988.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000228989.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000229102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000229105.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229105.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000229111.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000229118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229118.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000229122.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000229124.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000229195.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000229214.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229233.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000229233.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229263.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000229267.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000229267.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000229272.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000229276.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000229291.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229325.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000229348.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000229368.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000229388.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000229393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229401.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229463.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000229491.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229498.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000229502.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229512.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000229512.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000229558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229558.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000229563.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229563.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000229582.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000229582.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000229582.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000229582.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000229587.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000229611.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000229625.3 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000229647.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000229688.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000229697.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000229723.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000229727.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229766.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229801.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000229832.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000229839.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000229848.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000229852.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000229852.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000229869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000229873.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000229874.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000229891.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229905.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000229931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000229931.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000229951.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000229953.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000229953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229955.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000229980.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000229980.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000229983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000229989.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000229990.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000229999.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230021.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230023.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000230061.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000230082.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000230124.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230124.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000230126.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230172.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230177.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230212.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230289.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000230300.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000230303.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230310.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000230333.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230333.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230333.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000230337.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000230366.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230368.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000230394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230400.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000230408.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000230415.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000230417.6 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000230424.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000230427.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000230427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230470.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000230479.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230499.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000230499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230534.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230537.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000230537.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230555.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000230565.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230606.6 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230606.6 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000230613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230648.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000230648.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000230649.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230658.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000230679.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230679.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000230699.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230724.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230724.5 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000230732.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230732.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230735.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000230735.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230736.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230736.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230736.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000230747.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000230751.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000230790.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000230798.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000230815.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230815.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000230826.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000230834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230850.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000230850.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230880.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000230896.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000230896.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000230898.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000230899.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000230914.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230914.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000230922.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000230925.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000230937.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000230945.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231010.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231025.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000231028.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000231039.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000231057.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231064.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000231073.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000231073.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000231104.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231104.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231107.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231133.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231154.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231170.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231172.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000231172.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231185.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000231185.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231185.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000231193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231196.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000231227.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231242.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000231249.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231298.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231305.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231324.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000231327.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000231327.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231327.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000231329.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231335.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000231365.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000231367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231383.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231393.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231419.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000231439.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231439.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231459.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000231460.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231460.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231465.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231473.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231483.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000231483.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000231485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231507.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000231512.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231512.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000231527.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000231528.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231530.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000231533.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231536.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000231566.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000231574.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000231607.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000231609.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000231612.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000231613.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000231616.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231628.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231652.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231663.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000231704.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000231704.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000231720.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000231721.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000231728.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231728.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000231768.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000231769.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231770.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000231789.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000231789.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000231794.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000231795.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231795.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000231811.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231830.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000231840.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000231840.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231842.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231856.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231856.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000231865.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231882.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231889.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000231889.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231889.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231890.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000231901.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231903.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231927.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000231948.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000231969.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000231969.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000231992.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000231999.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000231999.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000232006.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232023.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000232028.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000232044.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232053.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232053.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000232057.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232063.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232063.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000232063.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000232065.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000232093.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000232098.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000232104.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000232116.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000232117.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000232131.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000232139.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000232160.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000232192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000232224.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000232259.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000232274.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000232284.3 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000232290.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000232300.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232316.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000232325.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232342.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232342.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000232342.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000232363.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232386.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232388.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000232406.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000232412.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000232442.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000232453.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000232453.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000232455.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000232455.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000232470.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000232518.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232527.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000232586.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232586.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000232593.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232611.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232611.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000232613.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000232618.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000232623.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000232633.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232638.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000232638.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000232640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232640.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000232648.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000232656.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232656.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000232677.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232693.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232693.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000232693.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232694.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000232712.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232729.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000232732.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232732.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000232739.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000232759.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232788.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000232814.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000232827.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232828.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232837.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232874.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232874.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000232876.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232909.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232909.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000232931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000232931.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232931.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000232936.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000232940.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000232949.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232973.7 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000232973.7 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000232986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000232987.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233017.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233029.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000233033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233060.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233060.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000233069.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000233077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233086.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233098.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000233101.6 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000233101.6 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000233108.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233117.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000233144.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000233178.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233184.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000233208.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233215.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233221.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000233223.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233242.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233244.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000233246.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233251.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233251.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000233255.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000233255.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233255.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000233293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233304.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233330.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000233334.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000233334.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233483.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000233496.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000233509.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000233509.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000233515.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000233521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233532.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233554.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000233559.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000233559.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000233559.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000233602.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233610.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000233613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233621.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000233625.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233644.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233651.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000233651.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233654.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000233695.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000233714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233725.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000233757.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233757.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000233757.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233775.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233775.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000233776.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000233776.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000233783.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000233791.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000233797.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233806.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233806.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233806.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000233817.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233818.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000233825.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233844.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000233845.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233847.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000233847.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000233885.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233891.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000233893.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000233895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000233912.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000233922.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000233937.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000233967.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234006.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234006.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000234050.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234062.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234072.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000234084.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234084.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000234134.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234134.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000234141.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000234156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234160.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234160.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000234171.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000234181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234183.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000234197.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000234197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234210.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000234215.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000234252.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234252.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234255.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000234255.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234263.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234283.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000234290.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000234292.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000234311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234350.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000234350.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000234350.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000234352.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234390.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234405.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234428.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000234437.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000234445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234449.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000234456.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234459.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000234460.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000234509.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000234571.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234617.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000234617.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000234630.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234630.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000234630.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234650.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234650.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000234650.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000234678.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000234688.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234695.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000234771.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234789.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000234818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234883.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000234884.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234892.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234912.5 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234915.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000234917.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234917.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000234921.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234928.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000234936.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000234936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234936.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000234945.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234945.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000234945.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000234978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000234996.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235005.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235021.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235023.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235024.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235029.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000235029.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235029.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000235033.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235033.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235051.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235052.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235070.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235078.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000235078.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000235079.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235092.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235092.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235117.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235121.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000235138.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235172.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000235180.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235209.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000235209.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235214.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000235214.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000235246.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000235269.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000235296.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235296.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000235296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235298.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000235298.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000235313.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000235313.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000235314.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235314.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235319.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000235326.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000235335.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235335.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000235373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235381.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235387.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000235387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235397.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000235398.4 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000235408.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000235427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235461.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235461.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235475.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235477.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235481.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235488.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000235488.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000235494.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235526.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235527.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235527.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235529.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235545.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235545.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000235560.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235565.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000235586.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000235586.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000235586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235593.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235597.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000235609.4 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000235635.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000235641.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000235659.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000235660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235664.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000235703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235741.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000235760.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235770.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000235770.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235772.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000235781.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000235781.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000235781.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235781.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000235785.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235806.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235806.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000235820.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000235831.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000235831.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235872.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000235884.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235890.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235890.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235897.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000235897.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000235899.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235903.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235908.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000235910.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000235927.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000235934.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000235954.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000235999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000235999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236003.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000236008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236016.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236017.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000236021.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236031.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236039.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236066.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236066.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000236066.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236088.5 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000236140.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000236166.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236188.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000236194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236200.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000236209.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236209.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000236226.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236230.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000236234.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000236269.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000236269.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000236318.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236345.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236345.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000236358.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000236364.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236366.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236423.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236423.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000236426.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000236426.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000236426.3 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000236434.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000236438.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236438.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000236449.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000236471.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236498.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000236498.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000236514.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236519.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236537.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000236540.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000236545.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236556.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236558.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236558.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000236558.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236559.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000236611.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236658.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236665.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236668.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236671.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236703.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236711.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236711.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236760.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236790.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236799.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000236846.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236850.4 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000236869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236869.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236886.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000236889.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000236894.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000236896.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236896.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000236901.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000236936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000236936.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000236953.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000236991.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237015.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000237021.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237037.5 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000237037.5 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000237073.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000237094.7 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237094.7 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000237119.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000237125.4 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237126.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237138.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237149.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000237159.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237222.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000237250.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000237250.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000237253.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000237253.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000237280.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237280.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000237291.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237298.4 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000237298.4 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000237301.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000237310.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000237328.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000237331.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000237336.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237343.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237343.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000237380.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000237380.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000237385.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237387.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237404.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237407.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000237410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237419.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237429.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237436.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000237438.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237457.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237461.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000237476.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000237476.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237489.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000237491.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237491.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000237502.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000237512.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000237512.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237520.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000237520.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000237520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237587.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237594.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000237595.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237595.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000237605.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237643.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000237664.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000237686.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000237686.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000237689.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000237697.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237705.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237726.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237738.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237750.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237751.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237753.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000237756.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000237756.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237756.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000237768.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000237768.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237772.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000237773.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000237773.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000237786.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000237803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237819.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237852.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237853.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237857.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000237883.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000237886.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237899.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237903.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000237903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237903.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000237919.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237928.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237934.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000237940.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237940.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237943.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000237950.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000237976.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000237980.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000237998.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000238005.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000238009.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000238018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000238018.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000238031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000238035.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000238039.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000238042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000238062.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000238062.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000238107.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000238113.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000238113.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000238113.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000238113.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000238123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000238133.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000238141.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000238141.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000238160.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000238160.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000238164.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000238178.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000238178.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000238184.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000238186.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000238186.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000238197.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000238221.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000238260.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000238260.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000238260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000238261.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000238261.5 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000238279.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000238279.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000238280.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000238287.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000238287.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000239002.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000239219.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000239219.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000239265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000239335.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000239377.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000239445.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000239467.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000239569.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000239653.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000239653.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000239674.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000239828.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000239911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000239911.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000239930.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000239945.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000239994.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000240015.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000240032.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000240032.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000240050.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000240050.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000240050.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000240057.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000240063.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000240093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000240137.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000240143.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000240207.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000240254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000240291.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000240350.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000240373.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000240401.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000240401.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000240401.4 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000240401.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000240401.4 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000240449.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000240449.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000240453.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000240453.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000240535.4 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000240541.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000240549.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000240571.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000240618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000240618.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000240618.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000240710.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000240758.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000240770.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000240790.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000240859.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000240990.5 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000240990.5 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000241042.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000241054.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000241125.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000241180.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000241180.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000241219.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000241269.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000241269.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000241280.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000241288.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000241449.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000241449.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000241481.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000241505.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000241544.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000241560.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000241570.4 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000241593.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000241599.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000241679.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000241679.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000241720.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000241732.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000241769.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000241770.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000241772.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000241772.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000241832.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000241860.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000241886.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000241933.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000241954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000241954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000241954.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000242042.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000242078.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000242082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000242104.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000242104.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000242125.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000242136.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000242147.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000242190.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000242207.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000242282.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000242357.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000242474.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000242516.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000242516.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000242540.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000242569.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000242578.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000242622.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000242687.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000242687.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000242753.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000242767.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000242791.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000242798.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000242861.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000243008.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000243176.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000243193.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000243224.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000243224.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000243224.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000243243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000243243.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000243319.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000243368.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000243389.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000243389.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000243415.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000243479.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000243485.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000243533.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000243533.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000243636.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000243637.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000243637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000243637.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000243701.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000243766.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000243766.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000243797.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000243797.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000243810.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000243819.3 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000243849.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000243849.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000243944.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000243944.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000243960.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000244040.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000244055.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000244124.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000244124.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000244124.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000244161.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000244203.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000244215.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000244260.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000244265.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000244265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000244265.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000244265.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000244286.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000244286.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000244300.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000244332.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000244332.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000244332.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000244345.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000244345.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000244393.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000244459.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000244459.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000244564.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000244586.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000244625.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000244649.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000244676.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000244879.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000244879.3 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000244879.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000244926.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000244945.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000244968.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000244968.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000244998.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000244998.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000245059.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000245148.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000245149.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000245281.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000245526.4 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000245532.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000245534.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000245685.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000245694.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000245694.4 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000245719.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000245748.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000245849.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000245910.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000246174.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000246174.3 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000246331.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000246334.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000246334.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000246339.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000246379.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000246422.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000246451.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000246465.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000246465.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000246523.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000246528.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000246548.3 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000246560.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000246560.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000246582.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000246640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000246695.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000246790.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000246820.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000246851.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000246859.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000246877.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000246889.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000246898.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000246898.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000247081.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000247092.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000247131.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000247137.4 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000247193.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000247199.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000247199.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000247311.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000247311.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000247324.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000247324.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000247363.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000247372.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000247373.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000247373.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000247400.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000247416.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000247498.5 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000247679.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000247708.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000247735.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000247774.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000247774.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000247844.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000247934.3 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000248049.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000248131.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000248150.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000248150.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000248161.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000248161.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000248223.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000248240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248243.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248243.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000248245.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000248254.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000248323.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000248367.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000248367.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000248370.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000248416.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000248429.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248445.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248461.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000248468.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248473.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000248476.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248476.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000248494.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000248508.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248508.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000248544.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000248554.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000248559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248636.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000248636.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000248664.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248668.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000248668.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000248671.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248671.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000248690.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000248690.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000248693.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248698.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000248730.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000248752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000248758.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248758.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000248771.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000248774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248774.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000248774.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000248779.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248858.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000248866.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000248890.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000248896.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248896.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000248896.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000248925.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000248932.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000248968.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000248986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000248996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000249035.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000249084.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000249084.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000249125.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000249207.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000249207.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000249234.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000249249.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000249249.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000249279.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000249307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000249307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000249328.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000249348.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000249348.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000249356.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000249412.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000249417.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000249417.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000249430.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000249476.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000249487.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000249494.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000249509.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000249509.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000249532.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000249602.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000249635.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000249647.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000249650.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000249650.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000249655.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000249655.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000249664.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000249684.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000249684.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000249684.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000249706.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000249725.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000249738.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000249776.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000249786.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000249790.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000249791.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000249803.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000249806.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000249825.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000249846.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000249846.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000249846.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000249846.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000249870.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000249894.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000249898.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000249942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000249984.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000249996.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000250012.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000250012.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000250015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250027.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250027.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250027.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000250033.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250046.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250057.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000250069.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250069.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000250069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250069.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000250073.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250101.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250116.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000250132.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000250156.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000250159.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250159.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000250220.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000250240.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000250260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250260.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000250282.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000250282.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000250286.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250295.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000250295.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000250303.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000250303.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000250303.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000250312.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000250320.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250326.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250326.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250366.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250409.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250410.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000250410.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000250413.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250519.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250541.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000250582.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000250602.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250604.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250608.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000250608.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250616.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250659.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000250692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250734.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000250734.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250734.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000250734.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000250764.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000250765.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250786.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000250786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000250790.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250802.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250802.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000250842.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000250899.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000250899.3 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000250909.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000250910.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250917.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000250920.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000250920.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000250948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250950.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250988.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000250988.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000250988.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000250999.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000250999.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000251010.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000251026.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000251026.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000251031.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000251072.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000251085.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000251093.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000251136.4 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000251136.4 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000251138.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000251141.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000251143.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000251152.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000251161.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000251161.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000251164.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000251169.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000251175.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000251187.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000251194.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000251221.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000251221.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000251298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000251314.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000251331.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000251359.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000251365.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000251365.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000251381.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000251393.3 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000251396.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000251408.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000251455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000251460.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000251497.2 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000251497.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000251523.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000251523.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000251532.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000251533.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000251555.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000251555.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000251562.3 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000251577.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000251604.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000251611.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000251623.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000251661.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000251665.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000251867.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000253106.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253133.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000253141.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253161.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000253161.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253172.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000253174.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000253181.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253197.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000253210.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253227.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000253230.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253256.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000253263.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000253266.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253284.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253307.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253317.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253317.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000253327.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253347.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000253358.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253385.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000253385.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000253406.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000253476.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000253477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253508.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253513.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000253522.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253530.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253552.3 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000253559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253559.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000253562.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253576.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253607.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253616.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253618.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253636.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000253636.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000253641.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253642.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000253661.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000253678.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000253687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000253695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253704.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253730.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000253733.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253746.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000253746.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253848.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253859.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253859.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000253865.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253875.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253875.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000253878.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000253878.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000253878.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253893.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000253911.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000253921.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000253948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253948.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000253973.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253978.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000253978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000253986.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000254006.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000254027.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000254034.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000254042.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254099.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000254109.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000254119.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000254119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254142.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254142.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000254162.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000254162.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254162.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000254165.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000254165.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254177.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000254180.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254224.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254224.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000254231.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254246.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254266.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254286.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000254302.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254315.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000254370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254370.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254389.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000254401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000254418.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000254419.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254419.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000254427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254428.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000254431.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000254451.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254458.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254459.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000254468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254477.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254485.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254495.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000254510.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254538.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000254545.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254554.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000254560.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000254577.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254577.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254605.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000254607.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254610.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254615.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254615.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254615.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000254620.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254654.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254664.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000254671.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000254676.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000254688.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254691.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254691.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000254710.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000254718.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254718.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000254718.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000254734.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254802.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000254812.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254812.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000254812.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000254814.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254837.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000254847.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254847.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000254854.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000254869.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254869.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000254878.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000254900.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000254907.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000254910.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254936.3 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254973.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000254973.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000254973.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000254977.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000254985.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000254990.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255020.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255026.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000255027.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255027.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255028.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000255029.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000255050.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000255052.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000255090.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255094.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000255100.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000255100.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000255101.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255118.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255120.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000255135.3 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000255139.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000255153.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000255153.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000255164.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255165.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000255182.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255227.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255229.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255229.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000255237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000255241.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255248.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255310.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000255310.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255343.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000255367.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255428.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255435.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000255443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255449.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000255471.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255471.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000255474.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255474.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000255474.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000255495.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000255495.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000255495.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000255507.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000255507.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000255509.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255517.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000255521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255545.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000255557.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000255559.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255571.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255606.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255621.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000255669.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255693.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255717.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000255717.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000255727.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255843.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255920.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000255929.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255933.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000255933.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255959.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000255966.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255970.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000255970.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000255983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000255983.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000256006.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000256008.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256031.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256050.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256083.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256116.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000256116.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000256128.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256128.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256150.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000256150.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000256151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256164.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000256195.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000256232.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256248.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000256249.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256250.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256278.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256299.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256325.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000256377.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000256381.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256381.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000256403.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256417.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000256433.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000256448.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000256452.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000256458.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000256458.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000256481.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000256542.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256576.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000256588.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000256588.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256596.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256603.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000256650.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256690.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000256690.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000256712.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000256721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000256742.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000256751.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000256757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000256973.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000256973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000256982.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000256988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000257002.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000257027.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000257027.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000257027.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000257038.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000257038.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000257056.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000257058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000257058.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000257095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000257097.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000257105.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000257135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257151.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257151.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000257176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257221.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000257270.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257272.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000257285.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000257354.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257354.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000257366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257391.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257410.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000257433.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000257449.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000257467.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000257488.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000257497.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000257499.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000257507.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000257526.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000257526.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000257527.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000257527.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000257534.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257556.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000257556.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000257563.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257568.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257595.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000257596.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000257613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257647.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257647.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000257671.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000257681.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000257702.3 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000257702.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000257702.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000257718.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257740.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257740.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000257759.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000257808.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257808.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000257808.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000257808.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000257809.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257815.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257830.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000257831.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000257831.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000257890.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000257894.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000257894.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000257900.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000257913.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000257924.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000257924.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000257964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258017.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000258048.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000258082.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258096.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000258101.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000258102.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258181.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258188.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258199.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000258260.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258260.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000258279.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000258302.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258303.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000258314.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000258323.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258325.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000258325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258325.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000258334.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000258344.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000258345.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258354.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258355.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000258355.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000258378.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000258400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258407.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000258413.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000258422.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258441.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258441.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000258442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258443.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258450.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258454.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000258486.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000258515.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258520.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000258520.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258521.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000258525.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258526.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258534.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258561.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258561.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000258561.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000258592.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258601.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258602.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258609.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258612.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258620.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000258623.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000258633.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258636.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258646.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000258658.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000258658.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258661.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000258661.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258689.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258698.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258701.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000258730.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000258731.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000258733.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000258736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258760.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258789.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000258798.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000258811.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000258819.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258821.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000258825.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000258851.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000258857.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000258858.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258891.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258902.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258913.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258914.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258920.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000258922.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000258929.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000258929.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258938.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000258942.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000258959.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000258959.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000258982.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259005.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259031.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000259055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259058.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259081.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000259083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259116.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259129.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259129.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000259130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259138.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259138.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000259153.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259172.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000259182.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000259187.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000259212.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000259212.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000259215.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259219.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259230.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000259234.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000259235.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259248.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000259251.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259274.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000259274.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000259275.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000259275.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000259287.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259294.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000259296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259298.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000259327.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000259334.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000259343.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000259348.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000259354.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000259359.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000259364.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259364.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000259366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259376.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259377.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259377.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000259380.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000259408.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259408.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259410.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259415.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259418.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259422.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259423.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000259423.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259424.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000259424.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259426.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000259426.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000259438.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000259438.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000259442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259442.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000259442.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000259442.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000259442.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000259443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259444.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000259448.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000259453.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259462.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000259462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259469.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000259474.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000259476.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000259485.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259488.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000259488.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000259488.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000259508.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259514.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259523.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000259540.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259543.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259548.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259553.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259561.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259563.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000259583.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000259589.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259594.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000259604.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000259604.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259606.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000259606.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000259617.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000259618.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259618.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000259644.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259645.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000259645.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000259652.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259654.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000259656.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259656.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000259659.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000259664.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259668.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000259678.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259687.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000259687.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000259692.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000259692.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259694.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000259700.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000259702.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000259709.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000259709.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000259714.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259715.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259715.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259744.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000259758.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000259768.3 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000259768.3 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000259774.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000259783.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259792.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000259793.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259802.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000259804.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000259806.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259806.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000259807.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000259818.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259820.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259834.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259840.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259863.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259867.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000259867.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259881.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259881.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000259883.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000259883.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000259884.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000259894.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000259901.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000259921.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000259925.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259926.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000259935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259937.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259953.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259954.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259959.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259969.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259992.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259994.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259994.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000259999.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000259999.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260008.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000260011.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260011.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260018.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260022.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260025.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260034.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000260037.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000260059.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260077.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000260081.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260083.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260086.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260093.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000260095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000260123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260136.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260162.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260167.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260176.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260176.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260179.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260194.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260196.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000260196.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260196.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260196.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000260198.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260206.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260219.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260219.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000260228.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000260228.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000260260.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000260260.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260261.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260269.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260273.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000260281.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260281.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260281.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000260288.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000260293.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260296.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260296.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260296.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000260296.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000260310.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260317.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000260317.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000260328.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260331.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260351.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000260360.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260360.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260361.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260366.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000260367.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260369.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000260369.2 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000260381.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260388.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260400.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260411.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260418.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260418.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260425.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260441.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260464.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260469.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260470.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260475.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000260476.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260492.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260493.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260495.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000260496.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260507.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260519.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260528.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260528.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000260555.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260577.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000260583.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260583.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260589.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260589.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260591.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260591.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260604.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260614.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260616.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260625.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260626.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000260626.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260637.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260641.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000260645.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260646.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260646.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000260646.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000260647.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000260655.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260655.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000260657.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000260660.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260664.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000260672.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260672.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000260693.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260698.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260711.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260735.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000260743.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000260743.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260744.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000260751.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260757.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260773.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260774.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260792.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260796.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260796.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000260805.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260805.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260810.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000260814.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260816.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260823.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260830.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000260831.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260834.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260837.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260853.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000260855.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000260855.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260871.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260871.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000260874.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260874.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000260877.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260884.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260891.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000260891.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260898.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000260907.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260910.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000260912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260917.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260919.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000260919.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260920.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260920.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260924.2 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000260926.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260927.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000260931.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260931.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000260932.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260936.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260938.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000260938.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260940.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000260941.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000260947.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000260949.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000260949.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260949.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000260953.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000260954.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000260954.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260973.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000260977.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000260977.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000260979.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000260986.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000260986.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261002.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000261008.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000261013.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261019.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261019.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000261024.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261043.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261044.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261051.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000261051.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261055.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261064.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000261064.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000261069.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261069.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261079.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000261079.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261087.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000261094.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261096.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261096.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000261101.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000261103.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000261117.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000261131.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261131.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000261135.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261158.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261159.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261168.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261170.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261172.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261183.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000261185.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261186.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000261186.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261187.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261188.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261191.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261200.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000261200.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000261204.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000261211.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261216.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000261218.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000261250.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000261251.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261252.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000261253.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261268.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261280.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000261288.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261291.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000261318.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000261324.2 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000261327.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261350.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261355.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261357.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261360.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261366.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261366.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000261366.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261368.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261374.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261384.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261386.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261394.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261396.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000261399.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261399.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000261411.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261420.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261428.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261428.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000261433.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261433.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261438.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261455.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000261462.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261476.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000261476.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261488.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000261496.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261504.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261512.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261512.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000261513.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000261519.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261533.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261533.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000261534.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000261560.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000261574.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261578.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000261596.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261597.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261610.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261613.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261634.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261646.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000261654.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000261656.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000261662.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261663.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000261670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261692.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261693.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000261695.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261697.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261706.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261712.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261723.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000261729.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000261731.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000261731.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261736.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261758.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261770.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261775.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261777.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000261797.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000261798.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000261799.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261801.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000261816.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000261823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261824.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000261839.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000261840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261840.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000261864.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000261886.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000261888.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000261978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000262001.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000262094.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000262119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000262119.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000262136.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000262147.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000262151.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000262171.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000262171.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000262172.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000262172.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000262179.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000262222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000262228.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000262292.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000262294.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000262294.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000262296.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000262372.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000262410.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000262410.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000262412.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000262412.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000262434.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000262468.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000262482.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000262514.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000262514.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000262521.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000262558.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000262652.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000262668.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000262686.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000262692.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000262703.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000262721.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000262745.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000262768.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000262772.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000262837.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000262873.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000262879.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000262888.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000262905.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000262951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000262952.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000262973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000263011.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000263011.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000263011.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000263013.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000263015.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000263050.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000263050.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000263069.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000263069.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000263069.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000263080.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000263176.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000263182.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000263272.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000263300.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000263307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000263331.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000263345.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000263393.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263412.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000263427.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263466.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000263466.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000263499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263567.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000263586.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263603.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000263603.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263612.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000263624.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000263624.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000263627.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000263674.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263680.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000263683.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263720.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263731.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000263753.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263753.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000263766.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000263786.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000263847.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000263860.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000263862.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263874.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000263874.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000263884.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000263895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263906.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263982.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000263982.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000264007.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000264007.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000264026.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000264031.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000264043.2 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000264078.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000264112.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000264125.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000264167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000264222.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000264222.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000264235.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000264247.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000264273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000264304.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000264365.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000264469.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000264469.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000264520.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000264548.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000264569.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000264575.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000264575.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000264577.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000264589.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000264647.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000264659.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000264745.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000264745.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000264769.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000264808.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000264829.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000264853.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000264860.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000264860.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000264868.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000264868.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000264885.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000264895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000264895.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000264914.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000264920.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000265043.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265091.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265091.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000265094.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000265094.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265130.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265142.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000265148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000265148.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265206.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265242.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000265242.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000265282.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265316.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265342.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000265349.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265408.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265443.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000265443.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000265474.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000265478.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265490.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265490.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000265496.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000265496.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265511.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000265542.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000265625.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000265656.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000265688.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000265728.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265750.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000265766.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000265791.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000265800.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000265801.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000265908.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000265912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000265962.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000265992.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000266079.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000266088.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000266126.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266236.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000266289.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266290.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000266304.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000266304.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000266313.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000266340.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000266397.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000266401.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000266445.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000266446.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000266456.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000266498.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000266498.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000266538.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266538.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000266541.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000266560.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000266598.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000266601.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000266651.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000266654.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000266717.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000266718.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000266803.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000266805.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000266835.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000266844.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000266850.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000266895.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000266895.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000266903.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000266911.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000266912.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000266921.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266921.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000266922.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000266922.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000266923.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000266926.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266927.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266930.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000266930.2 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000266933.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000266935.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266936.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266936.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000266941.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000266955.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000266957.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266970.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266975.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000266975.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000266983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000266993.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000266993.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000266999.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267002.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267002.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000267003.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000267003.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000267004.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267006.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267010.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000267016.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000267016.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267018.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000267018.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267040.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267040.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267042.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000267042.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267053.2 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000267064.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000267064.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267067.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267079.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267095.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267104.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000267108.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000267123.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000267136.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000267138.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000267138.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267141.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000267143.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000267144.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267147.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267150.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267150.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267159.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000267159.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000267161.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267163.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267167.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267167.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267169.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000267169.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000267183.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000267193.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267194.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267198.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000267199.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000267199.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267202.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267211.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267212.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267212.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267221.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000267230.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267230.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267231.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267248.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000267248.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000267251.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267251.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000267251.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267254.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267272.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267272.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000267273.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267274.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267274.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000267278.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000267279.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267280.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267280.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267280.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000267280.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267284.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000267289.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000267298.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267298.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267302.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000267304.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267304.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267308.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000267311.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267313.2 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000267322.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000267325.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000267325.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000267327.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000267327.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267344.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267344.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267347.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267348.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267374.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000267374.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000267381.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000267388.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267395.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000267395.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000267395.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267395.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000267397.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000267397.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000267397.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000267405.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267414.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000267414.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267432.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000267454.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267457.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000267470.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267503.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000267505.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000267505.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000267522.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000267530.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267530.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000267535.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267543.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000267546.2 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267565.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267565.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000267575.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000267582.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267586.2 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267613.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267613.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267642.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267649.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267651.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267651.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267658.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000267666.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000267667.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000267672.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267712.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267731.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267737.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000267749.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000267758.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000267758.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267764.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267764.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000267764.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000267765.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267765.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267765.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000267778.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267786.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267787.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267787.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267798.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000267798.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000267834.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267834.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000267858.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000267868.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267871.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000267874.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000267874.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000267898.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000267898.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000267919.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000267934.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000267939.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000267940.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000268015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000268047.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000268047.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000268061.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000268061.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000268066.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000268093.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000268095.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000268189.2 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000268189.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000268201.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000268204.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000268204.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000268231.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000268262.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000268266.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000268307.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000268307.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000268364.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000268375.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000268392.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000268471.3 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000268499.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000268518.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000268520.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000268536.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000268536.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000268568.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000268573.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000268573.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000268583.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000268584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000268655.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000268670.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000268670.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000268683.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000268683.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000268743.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000268751.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000268751.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000268751.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000268764.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000268836.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000268912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000268913.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000268913.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000268931.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000268945.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000268947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000268947.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000268970.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000268970.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000268987.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269019.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269054.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000269082.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000269086.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269091.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269102.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000269148.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269161.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000269161.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000269194.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269202.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000269202.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000269220.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000269293.2 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000269321.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269352.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269352.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000269356.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269386.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269397.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000269399.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000269425.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269425.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000269444.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269463.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000269473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269473.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000269481.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269483.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000269487.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000269489.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269489.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269489.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000269553.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269600.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000269609.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000269621.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269640.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269646.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000269652.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269652.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000269653.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000269688.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000269694.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269737.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269745.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269752.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269792.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269806.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000269814.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000269814.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000269815.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000269825.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000269836.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000269836.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269843.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000269867.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000269867.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000269873.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000269892.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269893.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269894.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000269895.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269895.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269903.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269906.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000269906.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000269908.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269910.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000269916.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000269918.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269919.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000269925.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000269925.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000269938.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269942.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000269944.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000269946.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000269947.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269947.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000269949.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000269951.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269956.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000269959.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269959.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000269961.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000269961.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269962.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000269970.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269971.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269973.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269978.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000269997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000269999.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000270000.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000270001.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000270006.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000270009.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270009.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000270010.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000270012.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270012.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000270018.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270019.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000270028.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270028.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000270035.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270039.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270048.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000270055.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000270061.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270062.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000270068.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000270069.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270072.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270074.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000270084.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270095.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270103.2 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000270104.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000270108.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000270108.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000270109.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270109.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000270109.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000270112.2 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270115.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000270117.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270127.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270130.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270133.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270133.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000270133.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000270140.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270141.2 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000270143.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000270145.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000270154.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000270154.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270157.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000270157.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000270159.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000270168.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000270170.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000270171.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270178.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000270184.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000270189.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270189.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270190.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000270190.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270210.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000270223.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270223.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270237.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270237.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270246.2 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000270302.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000270332.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270332.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000270332.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000270344.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000270346.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000270346.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000270361.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000270426.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000270462.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000270482.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270523.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270557.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270557.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270557.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000270580.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000270604.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270605.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270605.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270605.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000270640.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000270640.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000270659.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000270673.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270704.2 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270720.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270720.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000270720.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000270750.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270828.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000270933.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000270949.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000270964.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000270988.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000270996.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000270996.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271020.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000271032.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000271119.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271127.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000271127.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000271147.3 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000271192.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000271192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271200.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000271204.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000271204.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000271228.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000271234.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000271265.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271265.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271270.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000271308.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000271327.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000271335.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271347.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271359.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000271359.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000271366.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000271367.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000271398.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271398.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271398.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000271427.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271551.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271551.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000271551.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000271553.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000271554.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000271576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271576.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271576.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000271584.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000271590.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271643.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000271659.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271716.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271734.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000271738.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271738.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000271738.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271738.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000271755.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271757.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271757.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000271757.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000271762.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000271778.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000271780.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000271781.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000271782.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271782.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271789.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271789.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000271803.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271821.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271824.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000271824.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000271826.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000271826.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000271830.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271833.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271840.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271840.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000271848.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271849.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000271849.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000271851.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000271856.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000271857.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271862.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000271874.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000271888.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000271914.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271916.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271927.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271927.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271938.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271938.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000271938.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000271948.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271948.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271963.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271964.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271975.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000271981.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000271983.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000271991.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000271993.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000271993.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000271997.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272002.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272003.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000272005.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272010.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272024.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000272029.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000272033.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272033.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000272040.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000272048.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272048.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000272049.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272057.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000272068.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272070.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000272072.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272076.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272077.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272077.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000272077.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272079.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000272081.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000272087.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000272088.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272093.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272097.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272102.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000272121.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000272137.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272137.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272142.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272143.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272146.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000272148.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272156.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000272156.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000272158.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000272192.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000272192.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272192.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000272198.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000272198.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000272205.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272216.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272216.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000272216.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272217.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272217.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272221.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000272225.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272236.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272240.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272240.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272248.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272250.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000272255.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272263.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272263.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000272264.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000272264.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000272273.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000272273.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272275.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000272275.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000272275.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000272288.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272301.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272316.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272327.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272327.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000272334.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272334.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000272341.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000272343.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272354.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272361.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000272362.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000272365.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272370.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272372.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000272372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272375.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272379.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000272379.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272386.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272389.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000272416.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272420.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272420.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272432.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000272438.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272440.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000272449.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272452.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272452.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272455.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272455.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272463.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000272463.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000272468.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000272468.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272473.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272489.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272498.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272512.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272516.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272518.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000272518.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000272520.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000272523.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000272524.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272524.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000272524.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272525.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272529.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272529.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272529.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000272554.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000272556.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272558.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000272562.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272574.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272576.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272576.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000272604.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000272610.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272619.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272620.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272627.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000272639.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000272639.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272650.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000272657.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000272659.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000272660.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272662.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272667.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000272677.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272682.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272682.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272690.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272692.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272699.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272702.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000272707.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000272707.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000272716.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272717.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000272717.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272719.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272720.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272732.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272732.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272732.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000272733.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272744.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272744.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000272746.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000272754.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272761.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272763.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000272763.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272769.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000272777.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272777.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272780.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272787.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272788.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272792.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272792.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000272795.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272797.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272798.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272798.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272800.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000272800.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272800.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272808.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000272808.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272812.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272812.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272823.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272823.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272839.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272846.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272848.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000272849.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272849.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272849.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000272858.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272861.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000272862.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272864.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272870.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000272870.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000272870.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000272871.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272872.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272892.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272902.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000272905.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000272911.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000272912.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272914.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000272915.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272917.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272931.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000272931.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272933.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272940.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000272940.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000272940.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272942.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272949.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000272954.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272960.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272960.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000272966.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272966.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272971.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272977.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272983.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000272989.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272989.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000272989.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000272993.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000272995.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273000.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273004.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000273008.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000273011.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000273014.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000273015.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273015.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000273017.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273026.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273026.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000273035.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000273035.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273035.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000273056.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273056.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000273058.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000273059.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000273065.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000273065.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273066.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273075.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273075.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000273081.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273084.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000273117.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000273123.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273124.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000273125.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000273131.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000273132.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273142.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000273143.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000273143.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000273148.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000273156.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273156.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000273156.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273156.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000273160.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000273162.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000273175.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273175.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000273175.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000273176.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273179.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273181.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273186.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000273190.1 |
Predicted lncRNA |
Stomach adenocarcinoma |
|
| Ponatinib |
ENSG00000273203.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273203.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000273203.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273209.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273209.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000273230.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000273230.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000273233.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273233.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000273237.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000273240.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000273240.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000273245.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000273247.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273248.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000273257.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000273270.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000273281.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000273284.1 |
Predicted lncRNA |
Esophageal cancer |
|
| Ponatinib |
ENSG00000273290.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273293.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000273293.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273295.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000273297.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273297.1 |
Predicted lncRNA |
Breast invasive carcinoma |
|
| Ponatinib |
ENSG00000273306.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273308.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000273308.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273308.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000273319.1 |
Predicted lncRNA |
Lymphoid neoplasm diffuse large B-cell lymphoma |
|
| Ponatinib |
ENSG00000273321.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273321.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273325.1 |
Predicted lncRNA |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
|
| Ponatinib |
ENSG00000273325.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273329.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000273338.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000273342.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000273343.1 |
Predicted lncRNA |
Pancreatic adenocarcinoma |
|
| Ponatinib |
ENSG00000273344.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000273353.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000273355.1 |
Predicted lncRNA |
Bladder urothelial carcinoma |
|
| Ponatinib |
ENSG00000273372.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273373.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273375.1 |
Predicted lncRNA |
Chronic Lymphocytic Leukemia |
|
| Ponatinib |
ENSG00000273402.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273406.1 |
Predicted lncRNA |
Skin cutaneous melanoma |
|
| Ponatinib |
ENSG00000273437.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273437.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273442.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273442.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273443.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000273443.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273445.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273449.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273454.1 |
Predicted lncRNA |
Liver hepatocellular carcinoma |
|
| Ponatinib |
ENSG00000273456.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273471.1 |
Predicted lncRNA |
Ovarian serous cyStomach adenocarcinomaenocarcinoma |
|
| Ponatinib |
ENSG00000273471.1 |
Predicted lncRNA |
Thyroid carcinoma |
|
| Ponatinib |
ENSG00000273472.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273472.1 |
Predicted lncRNA |
Head and neck squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273472.1 |
Predicted lncRNA |
Sarcoma |
|
| Ponatinib |
ENSG00000273473.1 |
Predicted lncRNA |
Colon adenocarcinoma |
|
| Ponatinib |
ENSG00000273481.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273487.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|
| Ponatinib |
ENSG00000273488.1 |
Predicted lncRNA |
Brain lower grade glioma |
|
| Ponatinib |
ENSG00000273492.1 |
Predicted lncRNA |
Lung squamous cell carcinoma |
|